Table 5 Clinical outcomes after liver transplantation between ABO-C and ABO-I liver transplant recipients.

From: Prevalent metabolic derangement and severe thrombocytopenia in ABO-incompatible liver recipients with pre-transplant plasma exchange

 

Crude

PS-matched set

Event (%)

OR

95% CI

P value

Event (%)

OR

95% CI

P value

Intensive care unit ≥7 days*

  ABO-C

129 (14.0)

1

  

28 (14.1)

1

  

  ABO-I

30 (15.0)

1.09

0.71–1.67

0.707

30 (15.1)

1.08

0.62–1.89

0.776

Acute kidney injury‡

  ABO-C

539 (58.4)

1

  

108 (54.3)

1

  

  ABO-I

137 (68.5)

1.55

1.12–2.15

0.008

137 (68.8)

1.88

1.24–2.85

0.003

 

Event (%)

HR

95% CI

P value

Event (%)

HR

95% CI

P value

30-day mortality

  ABO-C

13 (1.4)

1

  

3 (1.5)

1

  

  ABO-I

2 (1.0)

0.71

0.16–3.13

0.647

2 (1.0)

0.66

0.11–3.97

0.654

6-month mortality

  ABO-C

37 (4.0)

1

  

7 (3.5)

1

  

  ABO-I

4 (2.0)

0.49

0.18–1.38

0.179

4 (2.0)

0.57

0.17–1.93

0.364

Overall mortality

  ABO-C

90 (9.8)

1

  

15 (7.5)

1

  

  ABO-I

9 (4.5)

0.46

0.23–0.91

0.026

9 (4.5)

0.61

0.27–1.39

0.236

Overall graft failure

  ABO-C

95 (10.3)

1

  

17 (8.5)

1

  

  ABO-I

14 (7.0)

0.69

0.39–1.21

0.194

14 (7.0)

0.85

0.42–1.73

0.663

  1. ABO-C, ABO-compatible; ABO-I, ABO-incompatible; CI, confidence interval; HR, hazard ratio; OR, odds ratio; PS, propensity score.
  2. Acute kidney injury‡: Classified according to Kidney Disease: Improving Global Outcomes.
  3. Intensive care unit ≥7 days*: Compared to intensive care unit <7 days.
Back to article page